Trials / Completed
CompletedNCT00728780
Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Capsules Relative to That From Co-administration of ABT-335 and Rosuvastatin for the 5/45mg Dosage Form.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the pharmacokinetics of ABT-335 and rosuvastatin from ABT-143 relative to that from the co-administration of ABT-335 and rosuvastatin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABT-143 | once |
| DRUG | ABT-335 and rosuvastatin | once |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2008-09-01
- First posted
- 2008-08-06
- Last updated
- 2012-09-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00728780. Inclusion in this directory is not an endorsement.